Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments
for
Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer,
Location: Montreal
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07468071
Phase1, Phase2, Recruiting
A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer
Location: Fairfax VA
Sponsor: Avistone Biotechnology Co., Ltd.
Sex: All
Age: 18+
Code: NCT07538804
Phase1, Phase2, Recruiting
HEARTS Trial for Thoracic Cancers
for
Non-Small Cell Lung Cancer (Stage III),
Location: Madison WI
Sponsor: University of Wisconsin, Madison
Sex: All
Age: 18+
Code: NCT07132918
Phase2, Recruiting
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Location: Lake Success NY, Grand Rapids MI, Houston TX,
Sponsor: MacroGenics
Sex: All
Age: 18+
Code: NCT06242470
Phase1, Recruiting
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
for
Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer
Location: Farmington Hills MI, Indianapolis IN, Dallas TX,
Sponsor: Hummingbird Bioscience
Sex: All
Age: 18+
Code: NCT06956690
Phase1, Phase2, Recruiting
A Study of MGC028 in Participants With Advanced Solid Tumors